Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

During a Senate Appropriations Committee hearing held on May 22, 2025, Senator Jon Ossoff Presses FDA Commissioner Marty Makary on the agency firing scientists and inspectors.

Layoffs at HHS create opportunities for local biotech and life sciences companies to add talent and prevent what many fear ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers to return, three sources close to the matter ...

The FDA will prioritize reviews of chemicals including butylated hydroxytoluene (BHT); butylated hydroxyanisole (BHA); and ...

An HHS official wrote in an email that critical programs within the FDA will continue, and the layoffs were related to administrative staff positions. The agency did not confirm how many staff ...

Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways. The cuts will likely have the greatest impact ...

The recall reverses firings carried out roughly a month ago by the Department of Health and Human Services, which oversees the agency.